Alar Pharmaceuticals Inc(TW:6785)
NT$80.10+3.60 (+4.71%)
TW:6785
Alar Pharmaceuticals Inc financials statements
NT$80.10
At close:+3.60 (+4.71%)
Alar Pharmaceuticals Inc (6785) Income Statement
Alar Pharmaceuticals Inc Income Statement
Last quarter (Q2 2026), Alar Pharmaceuticals Inc's total revenue was NT$1.25M, a decrease of 0.24% from the same quarter last year. In Q2, Alar Pharmaceuticals Inc's net income was NT$15.58M. See Alar Pharmaceuticals Inc’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| NT$ 2.75M | NT$ 5.82M | NT$ 469.27M | NT$ 800.00K | NT$ 0.00 | |
| NT$ -2.73M | NT$ 3.79M | NT$ 469.27M | NT$ 800.00K | NT$ 0.00 | |
| NT$ 165.07M | NT$ 71.73M | NT$ 83.75M | NT$ 47.33M | NT$ 93.30M | |
| Depreciation and Amortization | NT$ 4.87M | NT$ 3.88M | NT$ 3.35M | NT$ 3.21M | NT$ 3.36M |
| NT$ -74.02M | NT$ 49.50M | NT$ 394.52M | NT$ -29.31M | NT$ -60.85M | |
| NT$ -167.80M | NT$ -67.94M | NT$ 385.53M | NT$ -46.53M | NT$ -93.30M | |
| NT$ 88.83M | NT$ 104.99M | NT$ 5.58M | NT$ 13.99M | NT$ 29.06M | |
| NT$ -78.97M | NT$ 37.05M | NT$ 391.11M | NT$ -32.54M | NT$ -64.23M | |
| NT$ -79.68M | NT$ 18.17M | NT$ 382.62M | NT$ -19.87M | NT$ -64.23M | |
| Per Share Metrics | |||||
| Basic EPS | NT$ -1.19 | NT$ 0.27 | NT$ 6.71 | NT$ -0.35 | NT$ -1.13 |
| Diluted EPS | NT$ -1.19 | NT$ 0.27 | NT$ 6.71 | NT$ -0.35 | NT$ -1.13 |
| Weighted Average Shares Outstanding | 66.80M | 66.22M | 57.02M | 57.00M | 57.00M |
| Weighted Average Shares Outstanding (Diluted) | 66.80M | 66.22M | 57.05M | 57.00M | 57.00M |
Currency in TWD
